131 related articles for article (PubMed ID: 8592691)
1. Reconversion of fosphenytoin in the presence of intestinal alkaline phosphatase.
TenHoor CN; Stewart BH
Pharm Res; 1995 Nov; 12(11):1806-9. PubMed ID: 8592691
[No Abstract] [Full Text] [Related]
2. Rapid in vitro conversion of fosphenytoin into phenytoin in sera of patients with liver disease: role of alkaline phosphatase.
Dasgupta A; Schlette E
J Clin Lab Anal; 2001; 15(5):244-50. PubMed ID: 11574952
[TBL] [Abstract][Full Text] [Related]
3. Mathematical models to calculate fosphenytoin concentrations in the presence of phenytoin using phenytoin immunoassays and alkaline phosphatase.
Dasgupta A; Handy BC; Datta P
Am J Clin Pathol; 2000 Jan; 113(1):87-92. PubMed ID: 10631861
[TBL] [Abstract][Full Text] [Related]
4. Fosphenytoin.
Luer MS
Neurol Res; 1998 Mar; 20(2):178-82. PubMed ID: 9522355
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of in vitro models for screening alkaline phosphatase-mediated bioconversion of phosphate ester prodrugs.
Yuan H; Li N; Lai Y
Drug Metab Dispos; 2009 Jul; 37(7):1443-7. PubMed ID: 19372225
[TBL] [Abstract][Full Text] [Related]
6. Fosphenytoin (Cerebyx).
Browne TR
Clin Neuropharmacol; 1997 Feb; 20(1):1-12. PubMed ID: 9037568
[TBL] [Abstract][Full Text] [Related]
7. Probabilistic approach to the establishment of maximal content limits of impurities in drug formulations: the case of parenteral diphenylhydantoic acid.
Manca D; Walker RM; Krishna G; Graziano MJ; Kropko ML
Regul Toxicol Pharmacol; 1999 Feb; 29(1):1-14. PubMed ID: 10051414
[TBL] [Abstract][Full Text] [Related]
8. L-Phenylalanine inhibition of human alkaline phosphatases with p-nitrophenyl phosphate as substrate.
Komoda T; Hokari S; Sonoda M; Sakagishi Y; Tamura T
Clin Chem; 1982 Dec; 28(12):2426-8. PubMed ID: 7139925
[TBL] [Abstract][Full Text] [Related]
9. Fosphenytoin.
Eriksson K; Keränen T; Kälviäinen R
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):695-701. PubMed ID: 19473113
[TBL] [Abstract][Full Text] [Related]
10. Absorption rate limit considerations for oral phosphate prodrugs.
Heimbach T; Oh DM; Li LY; Forsberg M; Savolainen J; Leppänen J; Matsunaga Y; Flynn G; Fleisher D
Pharm Res; 2003 Jun; 20(6):848-56. PubMed ID: 12817887
[TBL] [Abstract][Full Text] [Related]
11. [In vivo determination of alkaline phosphatase activity of the intestine of the rainbow trout (Salmo gairdneri R.)].
Bussière D; Bogé G; Pérès G
J Physiol (Paris); 1987; 82(1):45-51. PubMed ID: 3430365
[TBL] [Abstract][Full Text] [Related]
12. Differences between duodenal and jejunal rat alkaline phosphatase.
Calhau C; Martel F; Hipólito-Reis C; Azevedo I
Clin Biochem; 2000 Oct; 33(7):571-7. PubMed ID: 11124343
[TBL] [Abstract][Full Text] [Related]
13. Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures.
Fischer JH; Patel TV; Fischer PA
Clin Pharmacokinet; 2003; 42(1):33-58. PubMed ID: 12489978
[TBL] [Abstract][Full Text] [Related]
14. Cysteamine S-phosphate hydrolysis by pure human alkaline phosphatases and by sera from patients with lymphoproliferative disorders.
Gainer AL; Stinson RA
Cancer Res; 1982 Sep; 42(9):3507-9. PubMed ID: 7105027
[No Abstract] [Full Text] [Related]
15. Bioavailability of intravenous fosphenytoin sodium in healthy Japanese volunteers.
Inoue Y; Usui N; Hiroki T; Shimizu K; Kobayashi S; Shimasaki S
Eur J Drug Metab Pharmacokinet; 2013 Jun; 38(2):139-48. PubMed ID: 22968854
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of phenytoin and anticonvulsant activity after oral administration of phenytoin-bis-hydroxyisobutyrate to rats.
Scriba GK; Lambert DM
Pharm Res; 1997 Feb; 14(2):251-3. PubMed ID: 9090719
[No Abstract] [Full Text] [Related]
17. The in vitro enzymic labilities of chemically distinct phosphomonoester prodrugs.
Kearney AS; Stella VJ
Pharm Res; 1992 Apr; 9(4):497-503. PubMed ID: 1495895
[TBL] [Abstract][Full Text] [Related]
18. A capillary GC-MS method for analysis of phenytoin and [13C3]-phenytoin from plasma obtained from pulse dose pharmacokinetic studies.
Nelson MH; Birnbaum AK; Nyhus PJ; Remmel RP
J Pharm Biomed Anal; 1998 Sep; 17(8):1311-23. PubMed ID: 9800650
[TBL] [Abstract][Full Text] [Related]
19. Fosphenytoin: a novel phenytoin prodrug.
Boucher BA
Pharmacotherapy; 1996; 16(5):777-91. PubMed ID: 8888074
[TBL] [Abstract][Full Text] [Related]
20. [Phosphoric esters of vitamin D2 and D3, new substrates for alkaline phosphatase of the bovine intestine].
Rapi G; Ginanneschi M; Chelli M; Pinzauti G; Vanni P
C R Seances Soc Biol Fil; 1983; 177(1):8-13. PubMed ID: 6303527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
